MicroMed Cardiovascular, Inc. has received a CE Mark extension to continue marketing its DeBakey VAD system in Europe ...
The FDA panel that convened for an intense, two-day review of drug-eluting stents last week heard key testimony from ...
A strong grassroots effort among physicians played a key role in staving off a Medicare physician payment cut that would ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
FUJIFLM Medical Systems USA, Inc. (“Fuji”) and Problem Solving Concepts, Inc. (“ProSolv”) have announced a co-marketing ...
Agfa HealthCare has signed a contract with the National Heart Centre (NHC) of Singapore, the national referral centre ...
The FDA panel that is re-evaluating the safety of drug-eluting stents convenes Dec. 7 and 8 at the Hilton Washington DC ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
Taking anti-platelet medication longer than current recommendations may lower heart attack or death risks for patients ...
Phase III of CoreValve’s international trial for its patented 18-French Revalving System is now one-third enrolled since ...
The FDA was notified on Dec. 2 that Pfizer will suspend a large, Phase 3 trial evaluating the investigational ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
The FDA will revisit a device tomorrow that it cleared for U.S. sale three years ago — drug-eluting stents will be the ...
The American Heart Association has published a report demonstrating that adolescent boys have a significantly increased ...
The Society for Cardiac Angiography and Interventions (SCAI) has extended the abstract deadline for its 30th Annual ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Pulse oximetry, which directly monitors the patient's oxygenation, came into its own as standard medical practice 20 ...
Toronto-based Cedara Software, a Merge Healthcare company and an independent developer of medical software technologies ...
Recent downplay of the media’s attention to DES-related thrombosis during both the TCT and AHA conferences this fall may ...
December 12, 2006
